The Cell and Gene Therapy Catapult (CGT Catapult) is an independent not-for-profit innovation and technology organisation committed to the advancement of cell and gene therapies.
Key information and resources provided on the site include:
CGT Catapult's guide on legislative changes regarding the development and marketing of ATMPs in the UK and EU post-BREXIT
CGT Catapult's presentation on current state of viral vector manufacturing, barriers, and solutions.
CGT Catapult's presentation on the regulatory framework for ATMPs in the EU, therapy classification, development support and market access pathways
CGT Catapult's information on market access processes for cell and gene therapies in EU
Additional information and resources developed by CGT Catapult:
